Augustine MK Choi, MDPrint this bio

CIMIT RESPONSIBILITIES

Co-Program Leader, Inhalation Technology

BACKGROUND

Augustine M.K. Choi, MD, is head of the Pulmonary and Critical Care Medicine Division at Brigham and Women’s Hospital, Co-Director of the Inhalation Technology Program at CIMIT and Francis B. Parker Professor of Medicine at Harvard Medical School. Previously he was at the University of Pittsburgh, Yale and Johns Hopkins.  His lab has made seminal observations that inhaled CO can confer cytoprotection in preclinical models of lung diseases.  Dr. Choi has been internationally recognized for his outstanding scientific contributions to the field, most recently at the 2010 American Thoracic Society International Conference in New Orleans, LA.

Dr Choi chairs CIMIT Inhalation Technology Program science review and educational programs. Since his arrival in Boston in 2008, when Dr. Choi founded the Harvard Lung Conference, he has been expanding a network of dedicated researchers, physicians, academics, and members of industry in the field of Pulmonary Disease and Medicine. In 2010, Dr. Choi and his colleagues at the Harvard Lung Conference determined the need for this first national-scale meeting, to due to the incredible wealth of new findings and advancements in the field.

Under the leadership of Dr. Choi, a diagnostic and therapeutic gaseous molecule laboratory has been established at the BWH. This lab provides for pre-clinical small animal testing for gases (NO, CO, Xenon, etc.) in lung disease models (i.e. sepsis, ARDS, PAH, COPD, progression of pulmonary fibrosis, ventilator induced lung injury, pneumonia) and for organ protection (i.e. TBI, Stroke, Cardiac, Liver, Kidney, etc.).